News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski
May 10, 2024, 16:40

Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: Prospective biomarker study finds preexisting cytopenias and hyperferritinemia predict long duration of post-CAR T-cell cytopenias, which may relate to immune remodeling with shift in CAR-negative T-cell subsets following therapy.”

Source: Robert Orlowski/X

Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study

Authors: Xiang Zhou, Vivien Wagner, Lukas Scheller, Emilia Stanojkovska, Christine Riedhammer, Xianghui Xiao, Maximilian Johannes Steinhardt, Cornelia Vogt, Silvia Nerreter, Florian Eisele, Mara John, Umair Munawar, Sofie-Katrin Kadel, Julia Mersi, Anna Ruckdeschel, Sven Schimanski, Larissa Haertle, Johannes Waldschmidt, Seungbin Han, Max Topp, Johannes Duell, Hermann Einsele, Angela Riedel, K. Martin Kortüm, and Leo Rasche.

Myeloma Paper of the Day

Other insights by Robert Orlowski on OncoDaily.

Angela Riedel Anna Ruckdeschel cancer Christine Riedhammer Cornelia Vogt Emilia Stanojkovska Florian Eisele Hermann Einsele Johannes Duell Johannes Waldschmidt Julia Mersi K. Martin Kortüm Larissa Haertle Leo Rasche Lukas Scheller Mara John Max Topp Maximilian Johannes Steinhardt MD Anderson Cancer Center Myeloma Paper of the Day OncoDaily Oncology relapsed/refractory multiple myeloma Robert Orlowski Seungbin Han Silvia Nerreter Sofie-Katrin Kadel Sven Schimanski Umair Munawar Vivien Wagner Xiang Zhou Xianghui Xiao
Special Coverage
Insight
Dec 22, 2024, 00:21
Eric J. Small: ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed
Blog
Dec 21, 2024, 22:40
50 Years of History, a Future to Write Together - AIEOP
Science
Dec 21, 2024, 22:37
Breaking Down the Impact of Ionizing Radiation on Cancer
Blog
Dec 21, 2024, 22:35
Santiago Viteri: Latest findings from the BR.31 trial presented at the 2024 ESMO Congress
Blog
Dec 21, 2024, 22:33
ABIM will develop two new assessment options focusing on breast cancer and hematologic neoplasms
Blog
Dec 21, 2024, 22:28
Adekemi Oyewusi: EDUCARE - Supporting the medical treatment and education of those impacted by childhood cancer
Blog
Dec 21, 2024, 22:26
Anas Younes: Transforming outcomes for people living with Blood Cancer
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe